Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-01

Clinical Trial Update: A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 study update assessing the safety and efficacy of albiglutide in adults with type 2 diabetes; results were posted after completion in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tanzeum (albiglutide) (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-07-01